Negócios · 25/01/20121 min de leitura
Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled "Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling." The guidance is intended to clarify for applicants the requirements for product name placement, size, prominence, and frequency in promotional labeling and advertising for prescription human and animal drugs and biological products. This guidance finalizes the draft guidance published in January 1999.